Poor results with intensified maintenance chemotherapy in acute promyelocytic leukemia
This article has no abstract so we have provided the first paragraph of the full text.
A prospective, multicenter study by the Japan Adult Leukemia Study Group, JALSG APL97, has shown that moderately intensive intermittent maintenance chemotherapy is detrimental to the survival of patients with acute promyelocytic leukemia (APL) who have become negative for the PML-RAR
transcript after intensive consolidation chemotherapy.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Hot on the TRAIL of acute promyelocytic leukemiaNature Medicine News and Views (01 Jun 2001)